Shots:Rick and John spoke about the trial design and the results from the P-II OraGrowtH210 Trial and P-II OraGrowtH212 trial evaluating LUM-201 to treat pediatric growth hormone deficiencyThey also elaborated on the timeline of the further clinical development of LUM-201The interview gives an understanding of Lumos Pharma’s vision to develop new therapies…
